Les analystes financiers croient toujours en Aventis
Les trois derniers mois ont été terribles dans la biotech et très durs dans la pharma. Les analystes campent sur leurs positi...
Emmanuel Garessus
- ABB LTD N45.070.04%
- ALCON N79.820.33%
- RICHEMONT N145.050.17%
- GEBERIT N5870.21%
- GIVAUDAN N40260.68%
- HOLCIM N94.420.43%
- KUEHNE+NAGEL INT N177.85-3.24%
- LOGITECH N66.761.71%
- LONZA N584.82.38%
- NESTLE N87.650.68%
- NOVARTIS N90.91-0.22%
- PARTNERS GROUP N11141.41%
- ROCHE GS257.6-0.89%
- SIKA N207.10.39%
- SONOVA HOLDING AG262.13.39%
- SWISS LIFE HOLDING AG N840.80.12%
- SWISS RE N149.80.44%
- SWISSCOM N5440.74%
- UBS GROUP N25.960.74%
- ZURICH INSURANCE N581-0.34%
- ABB LTD N45.070.04%
- ALCON N79.820.33%
- RICHEMONT N145.050.17%
- GEBERIT N5870.21%
- GIVAUDAN N40260.68%
- HOLCIM N94.420.43%
- KUEHNE+NAGEL INT N177.85-3.24%
- LOGITECH N66.761.71%
- LONZA N584.82.38%
- NESTLE N87.650.68%
- NOVARTIS N90.91-0.22%
- PARTNERS GROUP N11141.41%
- ROCHE GS257.6-0.89%
- SIKA N207.10.39%
- SONOVA HOLDING AG262.13.39%
- SWISS LIFE HOLDING AG N840.80.12%
- SWISS RE N149.80.44%
- SWISSCOM N5440.74%
- UBS GROUP N25.960.74%
- ZURICH INSURANCE N581-0.34%